Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Concurrent Angiogenic and EGFR Blockade in Conjunction With Curative Intent Chemoradiation for Locally Advanced Head and Neck Cancer

NCT00140556 is registered in ClinicalTrials.gov with David M. Brizel, MD as lead sponsor.

NCT NCT00140556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00140556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Concurrent Angiogenic and EGFR Blockade in Conjunction With Curative Intent Chemoradiation for Locally Advanced Head and Neck Cancer
Lead sponsor
David M. Brizel, MD
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2005
Completion date
April 30, 2010
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer, pharynx cancer